Advanced glycation end products increased placental vascular permeability of human BeWo cells via RAGE/NF-kB signaling pathway

Eur J Obstet Gynecol Reprod Biol. 2020 Jul:250:93-100. doi: 10.1016/j.ejogrb.2020.04.058. Epub 2020 Apr 30.

Abstract

Objective: This study aimed to investigate the mechanisms of advanced glycation end products (AGEs) on cell tight conjunction and placental vascular permeability in BeWo cells.

Study design: Monolayer permeability assay and transmission electron microscopy were employed to reveal the transformation of the placental vascular permeability and cell tight conjunction. Immunofluorescence, western blot and RT-qPCR were adopted to determine the protein and mRNA levels. Anti-RAGE and NF-kB inhibitor (PDTC) were used to inactivate the RAGE/NF-kB signaling pathway.

Results: AGEs significantly decreased trans-epithelial electrical resistance (TEER), while increased paracellular permeability (P < 0.05). TEM showed that AGEs made cell junction loose. AGEs inhibited ZO-1 and Occludin expressions, while anti-RAGE or PDTC partially restored their levels. AGEs also significantly increased mRNA RAGE and NF-kB expressions in BeWo cells (P < 0.05), and their expressions were inhibited by anti-RAGEy or PDTC.

Conclusion: AGEs could reduce the expressions of ZO-1 and Occludin by activating RAGE/NF-kB signaling pathway, thus increasing placental vascular permeability.

Keywords: Advanced glycation end products; Human BeWo cells; RAGE/NF-kB pathway; Tight junctions.

MeSH terms

  • Capillary Permeability
  • Female
  • Glycation End Products, Advanced* / metabolism
  • Humans
  • NF-kappa B* / metabolism
  • Permeability
  • Pregnancy
  • Receptor for Advanced Glycation End Products / metabolism
  • Signal Transduction

Substances

  • Glycation End Products, Advanced
  • NF-kappa B
  • Receptor for Advanced Glycation End Products